OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Neurology is 59. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Transmembrane protein interacts with α-synuclein to confer risk of PD	431
Lymphatic propagation of α-synuclein	429
Promising results for antisense RNA therapy in mouse models of diffuse midline glioma	325
Brain stimulation aids walking after spinal injury	324
ANA2025 marks important milestones for the ANA and NINDS	312
Global synergistic actions to improve brain health for human development	303
Reply to ‘Perils and pitfalls of near-death experience research’	296
Nociceptive action of calcitonin gene-related peptide in the trigeminovascular system	265
Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms	263
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications	259
Genetic insights from Parkinson disease in African and African admixed populations	256
Neural cell state shifts and fate loss in ageing and age-related diseases	216
CD11c+ macrophages mediate brain-to-gut α-synuclein trafficking	215
Disease-specific modifications of tau protein	196
Continuous levodopa production by an artificial enzyme	195
TREM2 mediates phagocytosis in glioblastoma	177
SEQUINS — a new initiative to address disparities in neurology	175
Nir Giladi (1955–2024)	162
Spinal muscular atrophy treatment in utero	159
Gut macrophages involved in Parkinson disease pathogenesis	150
Rapidly progressive dementias — leukodystrophies as a potentially treatable cause	148
Mitochondrial DNA instability in Huntington disease	142
The Digitized Memory Clinic	140
Imperatives and co-benefits of research into climate change and neurological disease	136
The role of the gut microbiota in multiple sclerosis	132

The impact of rare genetic variants on Alzheimer disease	131
Ultrasound lets gene therapy into the brain	128
Psychosis-causing lesions mapped to a hippocampal circuit	128
Menopause influences tau pathology	108
Brain volume is associated with cognition in MS	106
Amyloid plaques: hotspots for microglial turnover	106
Challenges of combining multimodal data in assessment of people with traumatic brain injury	104
MRI-based deep learning for TLE diagnosis	99
Gene therapy for seizures in focal cortical dysplasia	96
Neurological care for LGBT+ people	94
Implementation of the 2024 revision of the McDonald criteria for multiple sclerosis	93
First trials test targeting of α-synuclein for Parkinson disease	88
The challenges of anti-tau therapeutics in Alzheimer disease	87
Author Correction: Viral pathogens increase risk of neurodegenerative disease	83
Precision neuroimmunology in multiple sclerosis — the horizon is near	82
Neuroinflammation predicts cognitive decline in FTD	82
Diversity, equity and inclusion in neurology	81
α-Synuclein pathology as a target in neurodegenerative diseases	77
Implications of AD plasma and PET biomarker discordance	77
Management of freezing of gait — mechanism-based practical recommendations	76
Parkinson disease pathology can originate in the kidney	76
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice	75
Food is brain medicine — relevance and translation to neurology	74
Neurosteroids alleviate seizures in rats	73
Glymphatic dysfunction in PD clinical progression	72
A new biological classification for Parkinson disease	71
Addressing disparities in neurology by building the workforce in LMICs	70
Thalamic inflammation — a therapeutic target for brain injury?	69
Ultrasound ablation treatment for PD	69
New IDEAS about amyloid, race and dementia disparities	67
Spinal cord stimulation for the treatment of chronic pain	63
Skull bone marrow changes in multiple sclerosis	62
Author Correction: Why won’t it stop? The dynamics of benzodiazepine resistance in status epilepticus	60
Coeliac disease as a model for understanding multiple sclerosis	59